Black Diamond Therapeutics, Inc. Quarterly Operating Lease, Payments in USD from Q1 2020 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Black Diamond Therapeutics, Inc. quarterly/annual Operating Lease, Payments history and growth rate from Q1 2020 to Q1 2024.
  • Black Diamond Therapeutics, Inc. Operating Lease, Payments for the quarter ending March 31, 2024 was $1.08M, a 2.76% increase year-over-year.
  • Black Diamond Therapeutics, Inc. annual Operating Lease, Payments for 2023 was $4.24M, a 44.6% increase from 2022.
  • Black Diamond Therapeutics, Inc. annual Operating Lease, Payments for 2022 was $2.94M, a 19.1% increase from 2021.
  • Black Diamond Therapeutics, Inc. annual Operating Lease, Payments for 2021 was $2.46M, a 470% increase from 2020.
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $1.08M +$29K +2.76% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q1 2023 $1.05M +$349K +49.7% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q1 2022 $702K +$332K +89.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q1 2021 $370K +$315K +573% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-11
Q1 2020 $55K Jan 1, 2020 Mar 31, 2020 10-Q 2020-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.